
Spravato has become an important treatment option for individuals struggling with depression that has not improved with traditional medications. One of the most common questions patients ask is how quickly it works and what kind of results they can expect over time. Unlike standard antidepressants, Spravato follows a different timeline due to its unique mechanism in the brain.
Spravato is an esketamine-based nasal spray that targets NMDA receptors and influences glutamate activity. This process helps improve communication between brain cells and supports the formation of new neural connections.
Because of this mechanism, Spravato does not rely on the slower pathways used by traditional antidepressants. Instead, it works on systems involved in mood regulation more directly, which can lead to faster symptom changes for some patients.
Many patients are curious about what they will feel immediately after their first session. Since Spravato is administered in a controlled medical setting, patients are monitored closely for both therapeutic effects and temporary side effects.
A noticeable shift in mood within hours or days
Reduced intensity of negative thoughts
A sense of mental clarity or calmness
Temporary sensations such as dizziness or dissociation during the session
While some individuals feel improvement quickly, others may not notice significant changes right away. This variation is normal and depends on individual brain chemistry.
Spravato is typically given more frequently during the initial phase to build its effects over time. This period is often when patients begin to see more consistent improvement.
Treatments are usually administered twice per week
This phase typically lasts about four weeks
Gradual reduction in symptom severity may occur during this period
By the end of the first month, many patients report a clearer reduction in depressive symptoms, although results can vary.
The timeline for noticeable improvement is different for each patient. Some individuals respond early, while others require multiple sessions to experience meaningful relief.
Early responders may feel changes within the first few treatments
Most patients notice improvement within two to four weeks
Continued sessions help stabilize and extend these benefits
Consistency during the treatment schedule is important to allow the therapy to reach its full effect.
After the initial phase, the frequency of Spravato sessions is gradually reduced. This helps maintain results while minimizing the need for frequent visits.
Treatments may shift to once weekly
Eventually, sessions may be spaced every one to two weeks
Long-term improvements depend on continued monitoring and care
The goal of this phase is to sustain symptom relief and support ongoing mental stability.
Several factors can affect how quickly Spravato produces results. Understanding these variables can help set realistic expectations.
Severity and duration of depression
Previous response to antidepressant treatments
Overall health and brain chemistry
Consistency with the treatment schedule
Patients with long-standing or complex conditions may take longer to experience full benefits.
Spravato must be administered under strict medical supervision to ensure both safety and effectiveness. Each session includes monitoring before, during, and after dosing.
Dr. Alfredo Nudman provides individualized treatment plans that adjust based on patient response. This personalized approach helps optimize outcomes and ensures that progress is carefully tracked throughout the treatment process.
Spravato can begin working faster than traditional antidepressants, with some patients noticing early changes after the first few sessions. However, most individuals experience meaningful improvement within two to four weeks as the treatment builds over time. With proper medical guidance from Dr. Alfredo Nudman, patients can follow a structured plan designed to maximize results and support long-term mental health stability.

About the Author
Alfredo Nudman, MD

June 28, 2026